Carlota Dobano

ORCID, self-asserted

ORCID 0000-0002-6751-4060

Publications

Citations

h-index

Computed over the works the graph holds, so it is a floor rather than a career figure.

i10-index

Publications

6 works in the graph, newest first.

Determinants of long-term SARS-CoV-2 immune responses in asymptomatic-to-moderate COVID-19 patients in sub-Saharan Africa
2026BMC MedicineJournalOpen access2 citations10.1186/s12916-025-04607-9
Duration and association with protection of NANP-repeat-specific and C-terminus-specific anti-circumsporozoite protein IgG responses following RTS,S/AS01E vaccination: an observational ancillary immunological study of a phase 3 clinical trial
2026The Lancet Infectious DiseasesJournalOpen accessSenior authorCorresponding2 citations10.1016/s1473-3099(26)00081-2
The effect of Plasmodium falciparum exposure and maternal anti-circumsporozoite protein antibodies on responses to RTS,S/AS01E vaccination in infants and children: an ancillary observational immunological study to a phase 3, randomised clinical trial
2024The Lancet Infectious DiseasesJournalOpen accessSenior authorCorresponding10 citations10.1016/s1473-3099(24)00527-9
Malaria and other infections induce polyreactive antibodies that impact SARS‐CoV‐2 seropositivity estimations in endemic settings
2024Journal of Medical VirologyJournalOpen access7 citations10.1002/jmv.29713
The RTS,S malaria vaccine: Current impact and foundation for the future
2022Science Translational MedicineJournalCorresponding50 citations10.1126/scitranslmed.abo6646
Strong off-target antibody reactivity to malarial antigens induced by RTS,S/AS01E vaccination is associated with protection
2022JCI InsightJournalOpen accessSenior authorCorresponding17 citations10.1172/jci.insight.158030